Lincoln Pharmaceuticals Ltd achieves the milestone of Rs. 533 crore Revenue and Rs. 100 crore Profit before Tax for the first time in a Financial Year for FY2022-23

Mr. Mahendra Patel, MD, Lincoln Pharmaceuticals Ltd FY23 Results Highlights:– (Standalone) ·         Net Profit Reports Y-o-Y growth of 5.11% to Rs. 72.90 crore; ·         Total Income reports Y-o-Y growth of 10.52% to Rs. 532.79 crore; ·         EBITDA reports Y-o-Y growth of 5.86% to Rs. 111.65 crore. ·         Company recommends 15% Read more